1 year update 1mg finasteride daily. Update 4/5/2025
The user experienced significant hair regrowth in the temple area after using 1mg finasteride daily for over a year, with no side effects. The user did not use minoxidil or microneedling and started experiencing hair loss at age 16.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity 4ish month progress. 0.5mg oral Dut, 2.5mg oral min, occasional micro needling.
The user switched from finasteride to 0.5mg oral dutasteride and added 2.5mg oral minoxidil, along with occasional microneedling, to improve hair regrowth. They reported no side effects and are hopeful for continued progress, especially in the temple area.
community Slow and steady growth of hairline .One year progress
The user experienced hair regrowth using topical finasteride 0.1%, minoxidil 10%, and microneedling over a year, recovering about 5 years of hairline and 3 years of density. The treatment was applied to the temples and frontal area, with some recovery in the coronal area attributed to microneedling.
community 3 and half years - Fin, Min — and some micro needling
A nearly 50-year-old male achieved significant hair regrowth and thickening over three years using daily finasteride, twice-daily topical minoxidil, and bi-weekly microneedling with a dermastamp. He experienced no side effects and found microneedling particularly effective for the crown area.
community Can dut save my temples? I've been on fin for 2 years but im plateauing
OP is considering adding dutasteride to their regimen of finasteride and minoxidil to address hair loss plateauing. Users suggest oral minoxidil, microneedling, and possibly a hair transplant, with mixed opinions on dutasteride's effectiveness for temple regrowth.
community 6-Month Progress Update: Fin & Min
A 31-year-old experienced hair regrowth using a daily regimen of 5% minoxidil spray and 1mg oral finasteride over six months, with no side effects. The user noticed slow but positive progress, especially in the temple area, and plans to continue the treatment as advised by their doctor.
Related Research
6 / 6 results
research Managing patterned hair loss – a hair raising task!
This review summarizes existing knowledge on diffuse and patterned alopecia, emphasizing recent advancements in treatment beyond FDA-approved options, but it reports no new clinical findings.
research Potential application of PBM use in hair follicle organoid culture for the treatment of androgenic alopecia
This article discusses photobiomodulation as a potential adjunct to hair follicle organoid culture for androgenic alopecia, reporting no new results and suggesting further study is needed.
research Hair Restoration in Androgenetic Alopecia: Looking Beyond Minoxidil, Finasteride and Hair Transplantation
This review discusses the emerging pathophysiological factors and potential new therapies for androgenetic alopecia beyond traditional treatments, but reports no new results.
research AN OVERVIEW OF MEDICINAL PLANTS USED FOR THE TREATMENT OF HAIR LOSS
In this research, a thorough review of hair loss issues and treatments identified the effectiveness of minoxidil and finasteride for alopecia in the scalp's vertex region, but noted concerns about their potential long-term effects, leading to increased interest in herbal therapies.
research Combination of adipose-derived stem cell conditioned media and minoxidil for hair regrowth in male androgenetic alopecia: a randomized, double-blind clinical trial
In this study on male androgenetic alopecia, the researchers reported significant increases in hair count, density, and thickness with minimal side effects over 6 weeks using adipose-derived stem cell conditioned media and minoxidil, but found no significant differences between concentrated and non-concentrated treatments.
research Physiopathology and current treatments of androgenetic alopecia: Going beyond androgens and anti‐androgens
This review discusses the physiopathology of androgenetic alopecia and evaluates various traditional and emerging treatments, reporting no new clinical results but highlighting the need for enhanced treatment strategies.